Clinton Smith, Ph.D. candidate in the Lewis Lab, received a National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) F31 Individual Predoctoral Fellowship for his project titled “Cryptococcal nanotherapy: Engineering a novel fungus-based platform for improved drug delivery to the central nervous system.”
The prestigious fellowship provides tuition, stipend and educational support, enabling Smith to advance his innovative research under the mentorship of Dr. Jamal Lewis, associate professor and BME graduate coordinator in the J. Crayton Pruitt Family Department of Biomedical Engineering. His project aims to develop a unique drug delivery platform that uses the neurotropic fungus Cryptococcus neoformans to transport therapeutics across the brain’s protective barriers, with the goal of improving treatment for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Read more about BME Ph.D. Candidate Awarded NIH F31 NINDS Fellowship.
